The results identified Streptococcus suis, Escherichia coli, Mycoplasma hyopneumoniae, and Glaesserella parasuis as the most critical pathogens needing improved vaccines.
Veterinarians anticipated significant improvements in vaccine efficacy for S. suis and E. coli during the nursery stage and expressed a willingness to pay almost two per cent more than current prices.
While expectations for M. hyo vaccine improvements were not significant, veterinarians expressed the willingness to pay 4.2 times the current price because it could eradicate this disease.
One of the major benefits would be reduction of antibiotics to control these diseases.
